Literature DB >> 12774696

Phosphodiesterase type 5 (PDE5) inhibitors.

Helmut Haning1, Ulrich Niewöhner, Erwin Bischoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12774696     DOI： 10.1016/s0079-6468(02)41007-7

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  4 in total

1.  Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.

Authors:  Pengcheng Zhu; Lei Huang; Xiaona Ge; Fei Yan; Renliang Wu; Qilin Ao
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.

Authors:  E Y Oh; S K Bae; J W Kwon; M You; D C Lee; M G Lee
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

3.  Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes.

Authors:  Kevin D Schuster; Mohammadjavad Mohammadi; Karyn B Cahill; Suzanne L Matte; Alexis D Maillet; Harish Vashisth; Rick H Cote
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

Review 4.  Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System.

Authors:  Maria Rosaria Melis; Antonio Argiolas
Journal:  Biomolecules       Date:  2021-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.